TAK-583
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for TAK-583, covering 2012-02-02 to 2016-06-22. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of TAK-583 in Subjects With Diabetic Peripheral Neuropathy [Phase 2]